News Daily News As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions L.A. McKeown August 18, 2023
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Daily News Renal Denervation a Third Option for Hypertension, European Experts Say Todd Neale September 17, 2021
News Conference News ACC 2021 Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO Michael O'Riordan May 16, 2021
News Daily News ‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues Todd Neale June 24, 2019
News Conference News EuroPCR 2019 Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation L.A. McKeown June 06, 2019
News Daily News Renal Denervation Lowers BP in Sham-Controlled Studies: Meta-Analysis Michael O'Riordan April 02, 2019